Charles Schwab Investment Management Inc. Has $22.24 Million Stock Holdings in Oscar Health, Inc. (NYSE:OSCR)

Charles Schwab Investment Management Inc. lifted its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 3.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,654,862 shares of the company’s stock after acquiring an additional 54,696 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.67% of Oscar Health worth $22,241,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of OSCR. Victory Capital Management Inc. raised its position in shares of Oscar Health by 42.4% in the 3rd quarter. Victory Capital Management Inc. now owns 58,353 shares of the company’s stock worth $1,238,000 after acquiring an additional 17,377 shares in the last quarter. KBC Group NV increased its position in Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after buying an additional 1,328 shares in the last quarter. Swiss National Bank increased its position in Oscar Health by 17.8% in the 3rd quarter. Swiss National Bank now owns 314,900 shares of the company’s stock valued at $6,679,000 after buying an additional 47,500 shares in the last quarter. Intech Investment Management LLC bought a new stake in Oscar Health during the 3rd quarter worth approximately $1,282,000. Finally, Kingsview Wealth Management LLC bought a new stake in Oscar Health during the 3rd quarter worth approximately $446,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Jefferies Financial Group assumed coverage on Oscar Health in a research note on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price on the stock. Wells Fargo & Company downgraded Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price objective for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $20.19.

Oscar Health Trading Down 4.7 %

Shares of OSCR stock opened at $12.82 on Wednesday. The stock has a market capitalization of $3.21 billion, a price-to-earnings ratio of -640.43 and a beta of 1.75. Oscar Health, Inc. has a 1 year low of $12.43 and a 1 year high of $23.79. The company’s fifty day simple moving average is $15.16 and its two-hundred day simple moving average is $16.31. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. As a group, analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.